Why Viking Therapeutics Stock Zoomed 5% Higher Today
Good news from a peer and a positive analyst update were the elements driving Viking Therapeutics (NASDAQ: VKTX) stock higher on the first trading day of the week.
The clinical-stage biotech, closely watched by some because of its investigational weight-loss drug VK2735, saw its share price improve by more than 5% as a result. By contrast, the S 500 index basically traded flat across the trading session.
The news driving Viking and other obesity drug developers came from a leading company in that space, Wegovy maker Novo Nordisk.
Source Fool.com
Viking Therapeutics Inc Stock
€22.20
0.450%
With 8 Buy predictions and not the single Sell prediction the community is currently very high on Viking Therapeutics Inc.
Based on the current price of 22.2 € the target price of 45 € shows a potential of 102.75% for Viking Therapeutics Inc which would more than double the current price.
